The increased levels of death receptors and NKG2D ligands may render the tumour cells more sensitive to lysis by αβ T-cells, γδ T-cells and NK cells by increasing the chance that an interaction between an immune effector cell and a tumour cell will result in the death of the tumour cell. This evidence concerns the gene KLRK1 and neoplasm.